Glaxosmithkline Pharmaceuticals consolidated net profit rises 8406.98% in the March 2022 quarter

16 May 2022 , 05:16 PM

Net profit of Glaxosmithkline Pharmaceuticals rose 8406.98% to Rs 1219.05 crore in the quarter ended March 2022 as against Rs 14.33 crore during the previous quarter ended March 2021. Sales rose 8.76% to Rs 809.63 crore in the quarter ended March 2022 as against Rs 744.43 crore during the previous quarter ended March 2021. For the full year,net profit rose 373.19% to Rs 1694.72 crore in the year ended March 2022 as against Rs 358.15 crore during the previous year ended March 2021. Sales rose 12.05% to Rs 3278.03 crore in the year ended March 2022 as against Rs 2925.60 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	809.63	744.43	9	3278.03	2925.60	12
OPM %	21.64	21.05	–	23.24	20.45	–
PBDT	1467.41	196.33	647	2149.61	776.07	177
PBT	1452.06	178.65	713	2081.42	697.47	198
NP	1219.05	14.33	8407	1694.72	358.15	373

Powered by Capital Market – Live News